Alzheimer's Disease Is a Multi-Organ Disorder: It May Already Be Preventable

被引:6
作者
Eiser, Arnold R. [1 ,2 ]
Fulop, Tamas [3 ]
机构
[1] Univ Penn, Penn Ctr Publ Hlth, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Ctr Excellence Environm Toxicol, Environm Neurosci Grp, Philadelphia, PA 19104 USA
[3] Univ Sherbrooke, Ctr Aging, Sherbrooke, PQ, Canada
关键词
Alzheimer's disease; biotoxins; dementia; dysbiosis; environmental exposure; metabolism; neuroinflammation;
D O I
10.3233/JAD-221078
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In this commentary, we offer an overview of the several environmental and metabolic factors that have been identified as contributing to the development of Alzheimer's disease (AD). Many of these factors involve extracranial organ systems including immune system dysfunction accompanied by neuroinflammation (inflammaging), gastrointestinal dysbiosis, insulin resistance, and hepatic dysfunction. A variety of microbial factors including mouth flora, viruses, and fungi appear to play a significant role. There is a role for the colonic microbiome becoming dysbiotic and producing toxic metabolites. Declining hepatic function contributes diminished neuronal precursors and reduces toxin elimination. Environmental toxins especially metals play an important role in impairing the blood-brain barrier and acting synergistically with biotoxins and other toxic chemicals. Prevention and treatment of AD appears to require measuring several of these biomarkers and implementing corrective actions regarding such toxicants and correcting metabolic dysfunction at early or preclinical stages of this disorder.
引用
收藏
页码:1277 / 1281
页数:5
相关论文
共 50 条
  • [21] Prodromal cognitive disorder in Alzheimer's disease
    Touchon, J
    Ritchie, K
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1999, 14 (07) : 556 - 563
  • [22] Contactins & Alzheimer's Disease: Synaptic Proteins, Contactins may Contribute to the Pathology of Alzheimer's Disease
    Chatterjee, Madhurima
    Teunissen, Charlotte
    NEUROSCIENCE, 2020, 424 : 182 - 183
  • [23] Can Porphyromonas gingivalis Contribute to Alzheimer's Disease Already at the Stage of Gingivitis?
    Olsen, Ingar
    JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2021, 5 (01) : 237 - 241
  • [24] China Alzheimer's Disease and Neurodegenerative Disorder Research (CANDOR) -A Prospective Cohort Study for Alzheimer's Disease and Vascular Cognitive Impairment
    Li, S.
    Dong, H.
    Wang, Y.
    Wang, S.
    Lv, X.
    Dong, M.
    Tian, S.
    Shi, J.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2024, 11 (01): : 214 - 221
  • [25] Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer's Disease
    Aydin, Elber Yuksel
    Schneider, Andrea
    Protic, Dragana
    Wang, Jun Yi
    Martinez-Cerdeno, Veronica
    Tassone, Flora
    Tang, Hiu-Tung
    Perlman, Susan
    Hagerman, Randi J.
    CLINICAL INTERVENTIONS IN AGING, 2020, 15 : 285 - 292
  • [26] REM Sleep Behavior Disorder and Alzheimer's Disease: Definitely No Relationship?
    Galbiati, Andrea
    Carli, Giulia
    Hensley, Michael
    Ferini-Strambi, Luigi
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 63 (01) : 1 - 11
  • [27] Emotion Perception in Alzheimer's Disease and Mood Disorder in Old Age
    Phillips, Louise H.
    Scott, Clare
    Henry, Julie D.
    Mowat, Donald
    Bell, J. Stephen
    PSYCHOLOGY AND AGING, 2010, 25 (01) : 38 - 47
  • [28] Alzheimer's disease and vascular dementia: one potentially preventable and modifiable disease. Part I: Pathology, diagnosis and screening
    Davey, Dennis A.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2014, 4 (03) : 253 - 259
  • [29] Magnesium may be an effective therapy for Alzheimer's disease
    Lei, Dao-Yun
    Sun, Jie
    WORLD JOURNAL OF PSYCHIATRY, 2022, 12 (09): : 1261 - 1263
  • [30] Vascular risk factor detection and control may prevent Alzheimer's disease
    de la Torre, Jack C.
    AGEING RESEARCH REVIEWS, 2010, 9 (03) : 218 - 225